Cargando…

Characterisation of Glucose-Dependent Insulinotropic Polypeptide Receptor Antagonists in Rodent Pancreatic Beta Cells and Mice

Hypersecretion and alterations in the biological activity of the incretin hormone, glucose-dependent insulinotropic polypeptide (GIP), have been postulated as contributing factors in the development of obesity-related diabetes. However, recent studies also point to weight-reducing effects of GIP rec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Perry, RA, Craig, SL, Ng, MT, Gault, VA, Flatt, PR, Irwin, N
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Peptide based Therapies in Diabetes
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6743192/ https://www.ncbi.nlm.nih.gov/pubmed/31548798 http://dx.doi.org/10.1177/1179551419875453

Ejemplares similares

Nonclassical Islet Peptides: Pancreatic and Extrapancreatic Actions
por: English, Andrew, et al.
Publicado: (2019)

Multiagonist Unimolecular Peptides for Obesity and Type 2 Diabetes: Current Advances and Future Directions
por: Hasib, Annie
Publicado: (2020)

Dipeptidyl Peptidase-4 at the Interface Between Inflammation and Metabolism
por: Trzaskalski, Natasha A, et al.
Publicado: (2020)

Premises for Cholecystokinin and Gastrin Peptides in Diabetes Therapy
por: Rehfeld, Jens F
Publicado: (2019)

Molecular mechanism of an antagonistic antibody against glucose-dependent insulinotropic polypeptide receptor
por: Min, Xiaoshan, et al.
Publicado: (2020)

Alterations of Glucose-Dependent Insulinotropic Polypeptide and Expression of Genes Involved in Mammary Gland and Adipose Tissue Lipid Metabolism during Pregnancy and Lactation
por: Moffett, R. Charlotte, et al.
Publicado: (2013)

Gastric inhibitory polypeptide/glucose‐dependent insulinotropic polypeptide signaling in adipose tissue
por: Yamane, Shunsuke, et al.
Publicado: (2018)

A novel neurotensin/xenin fusion peptide enhances β-cell function and exhibits antidiabetic efficacy in high-fat fed mice
por: Perry, Rachele A., et al.
Publicado: (2021)

Searching for the physiological role of glucose‐dependent insulinotropic polypeptide
por: Holst, Jens Juul, et al.
Publicado: (2016)

Structural and Pharmacological Characterization of Novel Potent and Selective Monoclonal Antibody Antagonists of Glucose-dependent Insulinotropic Polypeptide Receptor
por: Ravn, Peter, et al.
Publicado: (2013)

SAT037 Glucagon-like Peptide-1 Receptor Knockout Mice Do Not Compensate For The Lack Of Incretin Action By Increasing Glucose-dependent Insulinotropic Polypeptide Secretion
por: Douglas Galsgaard, Katrine, et al.
Publicado: (2023)

Anti‐inflammatory role of glucose‐dependent insulinotropic polypeptide in periodontitis
por: Suzuki, Yuki, et al.
Publicado: (2016)

Roles of glucose‐dependent insulinotropic polypeptide in diet‐induced obesity
por: Seino, Yusuke, et al.
Publicado: (2022)

The Expression and Function of Glucose-Dependent Insulinotropic Polypeptide in the Embryonic Mouse Pancreas
por: Prasadan, Krishna, et al.
Publicado: (2011)

Glucose‐dependent insulinotropic polypeptide signaling in pancreatic β‐cells and adipocytes
por: McIntosh, Christopher HS, et al.
Publicado: (2012)

In Vivo Actions of Peroxisome Proliferator–Activated Receptors: Glycemic control, insulin sensitivity, and insulin secretion
por: Eldor, Roy, et al.
Publicado: (2013)

How Do We Continue Treatment in Patients With Type 2 Diabetes When Therapeutic Goals Are Not Reached With Oral Antidiabetes Agents and Lifestyle? Incretin versus insulin treatment
por: Gallwitz, Baptist, et al.
Publicado: (2013)

Is Physical Exercise a Core Therapeutical Element for Most Patients With Type 2 Diabetes?
por: De Feo, Pierpaolo, et al.
Publicado: (2013)

Activation of GPR40 as a Therapeutic Target for the Treatment of Type 2 Diabetes
por: Burant, Charles F.
Publicado: (2013)

Do We Still Need Pioglitazone for the Treatment of Type 2 Diabetes? A risk-benefit critique in 2013
por: Schernthaner, Guntram, et al.
Publicado: (2013)

miR-146a-5p Regulated Cell Proliferation and Apoptosis by Targeting SMAD3 and SMAD4
por: Qiu, Meiyu, et al.
Publicado: (2020)

Phosphorylation Regulation of a Histone-like HU Protein from Deinococcus radiodurans
por: Hou, Jinfeng, et al.
Publicado: (2022)

Purification, Partial Characterization, and Evaluation of the Antiulcer Activity of Calotropis procera Leaf Lectin
por: Al-Thobaiti, Saed A., et al.
Publicado: (2022)

Dysregulation of SNHG16(lncRNA)-Hsa-Let-7b-5p(miRNA)-TUBB4A (mRNA) Pathway Fuels Progression of Skin Cutaneous Melanoma
por: Chen, Guanghua, et al.
Publicado: (2022)

Mechanisms of fat‐induced gastric inhibitory polypeptide/glucose‐dependent insulinotropic polypeptide secretion from K cells
por: Yamane, Shunsuke, et al.
Publicado: (2016)

N‐terminally and C‐terminally truncated forms of glucose‐dependent insulinotropic polypeptide are high‐affinity competitive antagonists of the human GIP receptor
por: Hansen, L S, et al.
Publicado: (2016)

The gut hormone glucose-dependent insulinotropic polypeptide is downregulated in response to myocardial injury
por: Kahles, Florian, et al.
Publicado: (2022)

Structural insights into hormone recognition by the human glucose-dependent insulinotropic polypeptide receptor
por: Zhao, Fenghui, et al.
Publicado: (2021)

Somatostatin receptor 5 and cannabinoid receptor 1 activation inhibit secretion of glucose-dependent insulinotropic polypeptide from intestinal K cells in rodents
por: Moss, C. E., et al.
Publicado: (2012)

Glucose‐dependent insulinotropic polypeptide receptor antagonist treatment causes a reduction in weight gain in ovariectomised high fat diet‐fed mice
por: Boer, Geke Aline, et al.
Publicado: (2022)

Mechanisms underlying glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1 secretion
por: Reimann, Frank, et al.
Publicado: (2016)

Carbohydrate‐induced secretion of glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1
por: Seino, Yusuke, et al.
Publicado: (2016)

Characterization of (111)In-labeled Glucose-Dependent Insulinotropic Polypeptide as a Radiotracer for Neuroendocrine Tumors
por: Willekens, Stefanie M. A., et al.
Publicado: (2018)

HNF4α is a novel regulator of intestinal glucose-dependent insulinotropic polypeptide
por: Girard, Romain, et al.
Publicado: (2019)

Glucose-Dependent Insulinotropic Polypeptide Receptor-Expressing Cells in the Hypothalamus Regulate Food Intake
por: Adriaenssens, Alice E., et al.
Publicado: (2019)

Impacts of Glucose-Dependent Insulinotropic Polypeptide on Orthodontic Tooth Movement-Induced Bone Remodeling
por: Yamauchi, Taisuke, et al.
Publicado: (2022)

Special Collection on Electroporation-Based Therapies: A Selection of Papers From the Second World Congress on Electroporation
por: Heller, Richard, et al.
Publicado: (2019)

Exogenous Glucose–Dependent Insulinotropic Polypeptide Worsens Post prandial Hyperglycemia in T ype 2 Diabetes
por: Chia, Chee W., et al.
Publicado: (2009)

Glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1: Incretin actions beyond the pancreas
por: Seino, Yutaka, et al.
Publicado: (2013)

Glucose-Dependent Insulinotropic Polypeptide Mitigates 6-OHDA-Induced Behavioral Impairments in Parkinsonian Rats
por: Yu, Yu-Wen, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_pcsakemb4jmm6137kglqs9i2bf